Advances in proteomic strategies toward the early detection of lung cancer

Proceedings of the American Thoracic Society

Volumn 8, Issue 2, 2011, Pages 183-188

  Hassanein, Mohamed ^a   Rahman, Jamshedur S M ^a   Chaurand, Pierre ^b   Massion, Pierre P ^a,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biomarker; Early detection; Lung cancer; Proteomics

Indexed keywords

AUTOANTIBODY; HAPTOGLOBIN; PROTEIN TYROSINE KINASE; RETINOL BINDING PROTEIN; TRANSFERRIN; TRYPSIN INHIBITOR; TUMOR ANTIGEN; TUMOR MARKER;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; LUNG CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEOMICS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM CYTODIAGNOSIS; TANDEM MASS SPECTROMETRY; THORAX RADIOGRAPHY; VALIDATION PROCESS;

DISEASE PROGRESSION; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; PRECANCEROUS CONDITIONS; PROTEOMICS; RISK ASSESSMENT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 80051732155     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201012-069MS     Document Type: Conference Paper

References (54)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-13795. (Pubitemid 33115977)
4. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-1068. (Pubitemid 34092881)
5. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-824.
6. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001;98:13784-13789. (Pubitemid 33115976)
7. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-1907.
8. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000;355:479-485. (Pubitemid 30085163)
9. Patz EF Jr, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, et al. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. J Thorac Oncol 2010;5:1502-1506.
10. Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003;58:784-789. (Pubitemid 37094055)
11. Manser R. Screening for lung cancer: a review. Curr Opin Pulm Med 2004;10:266-271. (Pubitemid 38803118)
12. Pastorino U. Lung cancer screening. Br J Cancer 2010;102:1681-1686.
13. National Institute of Health NCIN. NCI Office of Media Relations. Twenty percent fewer lung cancer deaths seen among those who were screened with low-dose spiral CT than with chest X-ray. US NIH News 2010.
14. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005;5:845-856. (Pubitemid 41746029)
15. Ocak S, Chaurand P, Massion PP. Mass spectrometry-based proteomic profiling of lung cancer. Proc Am Thorac Soc 2009;6:159-170.
16. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, et al. Multisite assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009;27:633-641.
17. Gonzalez-Angulo AM, Hennessy BT, Mills GB. Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol 2010; 28:2777-2783.
18. Shen J, Behrens C, Wistuba II, Feng L, Lee JJ, Hong WK, Lotan R. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using highthroughput Western Array and immunohistochemistry. Cancer Res 2006;66:11194-11206. (Pubitemid 46009947)
19. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, Chaurand P, Yanagisawa K, Slovis BS, Miller RF, et al. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 2005;172:1556-1562. (Pubitemid 43076545)
20. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003; 362:433-439. (Pubitemid 36999706)
21. Groseclose MR, Massion PP, Chaurand P, Caprioli RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 2008;8:3715-3724.
22. Groseclose MR, Andersson M, Hardesty WM, Caprioli RM. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. J Mass Spectrom 2007;42:254-262.23. Liebler DC. Shotgun mass spec goes independent. Nat Methods 2004;1: 16-17.
23. Ong SE, Foster LJ, Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods 2003;29:124-130. (Pubitemid 36269199)
24. Yates JR III, Gilchrist A, Howell KE, Bergeron JJ. Proteomics of organelles and large cellular structures. Nat Rev Mol Cell Biol 2005;6: 702-714. (Pubitemid 41742794)
25. Takefumi Kikuchi QL. Robbert Slebos, Bing Zhang, Ming Li, Jamshedur Rahman, Lisa Zimmerman, David Tabb, Adriana Gonzalez, Daniel Liebler, David Carbone, and Pierre Massion: Shotgun proteomic analysis of non-small cell lung cancer. Proceedings of the 99th annual meeting of the American Association for Cancer Research 2008.
26. Sprung RW Jr, Brock JW, Tanksley JP, Li M, Washington MK, Slebos RJ, Liebler DC. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009;8:1988-1998.
27. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007;131: 1190-1203. (Pubitemid 350235027)
28. Menges CW, Chen Y, Mossman BT, Chernoff J, Yeung AT, Testa JR. A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma. Genes Cancer 2010;1:493-505.
29. Chaurand P, Sanders ME, Jensen RA, Caprioli RM. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol 2004;165:1057-1068. (Pubitemid 39297713)
30. Chaurand P, Norris JL, Cornett DS, Mobley JA, Caprioli RM. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res 2006;5:2889-2900. (Pubitemid 44749207)
31. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006;5:573-588.
32. Sidransky D, Irizarry R, Califano JA, Li X, Ren H, Benoit N, Mao L. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J Natl Cancer Inst 2003;95: 1711-1717. (Pubitemid 37521219)
33. Yildiz PB, Shyr Y, Rahman JS, Wardwell NR, Zimmerman LJ, Shakhtour B, Gray WH, Chen S, Li M, Roder H, et al. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol 2007;2:893-901. (Pubitemid 47511591)
34. Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, Herndon JE II. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 2007;25:5578-5583.
35. George SL. Statistical issues in translational cancer research. Clin Cancer Res 2008;14:5954-5958.
36. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-1061. (Pubitemid 32717537)
37. Srivastava S, Gopal-Srivastava R. Biomarkers in cancer screening: a public health perspective. J Nutr 2002; 132(8, Suppl)2471S-2475S. (Pubitemid 34848129)
38. Moons KG. Criteria for scientific evaluation of novel markers: a perspective. Clin Chem 2010;56:537-541.
39. Huang SN, Minassian H, More JD. Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. Lab Invest 1976;35:383-390.
40. Gergov M, Ojanpera I, Vuori E. Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. J Chromatogr B Analyt Technol Biomed Life Sci 2003;795:41-53. (Pubitemid 37289424)
41. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, Anderson NL, Borchers CH. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009;8:1860-1877.
42. Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B. Quantification of Creactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and C-13- labeled peptide standards. Proteomics 2004;4:1175-1186. (Pubitemid 38445974)
43. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004;3:311-326.
44. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomics using autoantibody signatures for biomarker discovery. Mol Cell Proteomics 2007;6:1115-1122. (Pubitemid 47099223)
45. Feng Z, Prentice R, Srivastava S. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. Pharmacogenomics 2004;5:709-719. (Pubitemid 39236584)
46. Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Proteomicsbased identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 2001;61:7908-7912. (Pubitemid 33049381)
47. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-519. (Pubitemid 47181397)
48. Zhong L, Hidalgo GE, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med 2005;172:1308-1314. (Pubitemid 43076570)
49. Khattar NH, Coe-Atkinson SP, Stromberg AJ, Jett JR, Hirschowitz EA. Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer. Cancer Biol Ther 2010;10:267-272.
50. Chen EI, Cociorva D, Norris JL, Yates JR III. Optimization of mass spectrometry-compatible surfactants for shotgun proteomics. J Proteome Res 2007;6:2529-2538. (Pubitemid 47122350)
51. Wu D, Gao Y, Chen L, Qi Y, Kang Q, Wang H, Zhu L, Ye Y, Zhai M. Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice. Peptides 2010;31:850-864.
52. Hanash S. Harnessing immunity for cancer marker discovery. Nat Biotechnol 2003;21:37-38. (Pubitemid 36055824)
53. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Tureci O, Wiewrodt R, Barnes AC, Robertson JF. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-233. (Pubitemid 351373718)
54. Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, Barnes A, Sewell HF, Fritsche HA, Robertson JF. Technical validation of an autoantibody test for lung cancer. Ann Oncol 2010;21:1687-1693.